Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VKORC1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
INPP5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00493 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CCDC94 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ICE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDSS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A42 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM219B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RGS14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PGM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNDBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCL2L11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTNNA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAU2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NANS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EML4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HACD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on